Join psychedelic-assisted psychotherapists Emily Tunks, Mark Baxter, Bianca Sebben and Monica Schweickle for a Q&A session about their work across a diverse range of contexts in Australia. In the MDMA and psilocybin-assisted therapy space they have extensive experience across clinical, research, regulatory, consultancy, supervisory and private practice settings.
This is an opportunity to ask any questions you have about practice, policy, training, trials, outcomes, lessons learned, and more. Questions like:
- What training do I need to work as a psychedelic assisted therapist?
- Can I offer psychedelic assisted therapy as part of my private practice as a psychologist?
- What are the risks and benefits of this therapy?
- How do I tell which clients will benefit?
- How can I refer my clients to private clinics?
- How can I find out about research trials coming up?
- What guidelines oversee these therapies?
Bring your curiosity and your questions for an interactive online session with the AAPi PAP Interest Group Co-Chairs.
About our presenters:
Emily Tunks is a psychologist with health endorsement and a Somatic Psychotherapist. Emily is also an Australian Research Trial PAT therapist since 2020, involved in several projects investigating psilocybin at Swinburne University (including intravenous/IV administration), and MDMA for PTSD in First Responders at Monash University/MAPS.
Bianca Sebben is a psychologist with clinical endorsement, founder of Conscious Insights, and co-founder and director of Indigenous Psychedelic Assisted Therapies (IPAT). Bianca provides training and supervision to psychedelic therapists particularly with post-psychedelic difficulties; and has worked as a trial therapist.
Mark Baxter is a psychologist in private practice in Wollongong. He is the Director of The Psychology Spot and provides MDMA and psilocybin-assisted therapy through Evolution MET and Tikvah in Sydney, as well as supervision.
Monica Schweickle is a co-founder and Director of The Peridot Clinic, a Newcastle-based service providing psychedelic-assisted therapy in NSW. She is also a co-founder and Director of The Psychedelic Consultancy, which supports the development of safe, ethical and compliant psychedelic-assisted therapy through regulatory and compliance guidance, protocol development, and training and supervision for psychiatrists, therapists and organisations establishing PAT within their practices.
Webinar timing: 7:00 – 8:30 pm AEDT
Access to the recording of this webinar: A recording of this webinar will be available through the CPD Webinar Library, but for the best experience and the opportunity to ask your questions, join us live. Everyone who registers will be advised via email as soon as the recording is available. Members have unlimited access to the recording, and non-members will have access for 6 months.